生物膜衍生纳米颗粒的概述,作为新兴的药物输送系统,用于治疗骨老化的疾病
Qicheng Li1, Tianze Sun1, Shiyan Liu2
1Department of Trauma and Orthopedics, Peking University People's Hospital, Beijing 100000, China; Key Laboratory of Trauma and Neural Regeneration, Peking University, Beijing 100000, China.
International journal of pharmaceutics
|June 11, 2025
概括
来自生物膜的纳米颗粒为治疗骨老化的疾病,如骨质疏松症和骨关节炎提供了一种新的方法. 这些先进的药物递送系统增强生物相容性和向性递送,提高治疗疗效和减少副作用.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 再生医学是一种再生医学.
背景情况:
- 骨老化的疾病,包括骨质疏松症和骨关节炎,对全球健康构成重大挑战.
- 目前的治疗方法往往具有不理想的结果和不良影响.
- 人口老龄化加剧了这些条件的负担.
研究的目的:
- 审查骨老化疾病的病理生理学.
- 评估当前的治疗策略.
- 探索生物膜衍生纳米颗粒治疗骨质疏松症和骨关节炎的潜力.
主要方法:
- 审查有关骨老化疾病和药物输送系统的现有文献.
- 专注于生物膜衍生的纳米粒子 (例如细胞膜,细胞外囊泡).
- 纳米粒子特性分析:生物相容性,循环时间,向传递和功能修饰.
主要成果:
- 来自生物膜的纳米颗粒显示出增强药物输送的前景.
- 这些系统提高了生物相容性,并延长了循环时间.
- 生物膜的功能性修改可以优化治疗性能,以实现有针对性的治疗.
结论:
- 生物膜衍生的纳米颗粒在治疗骨老化的疾病方面是一个有前途的进步.
- 这些系统有潜力提高治疗效率并最大限度地减少副作用.
- 进一步的开发可能会导致骨质疏松症和骨关节炎治疗的成功临床转化.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.


